|
|
Yes |
|
|
(n = 70) |
No |
|
|
|
(n = 137) |
|
|
|
|
Treatment setting |
In patient |
54 (77.1%) |
66 (48.2%) |
*<0.001 |
|
Outpatient |
16 (22.9%) |
71 (51.8%) |
|
Gender |
Male |
36 (51.4%) |
80 (58.4%) |
0.339 |
|
Female |
34 (48.6%) |
57 (41.6%) |
|
Diagnosis |
Leukemia/ lymphoma |
28 (40.0%) |
82 (59.9%) |
*0.007 |
|
Solid |
28 (40.0%) |
36 (26.3%) |
*0.043 |
|
CNS |
14 (20.0%) |
19 (13.9%) |
0.254 |
Acute Nausea Degree categorize |
No Nausea |
17 (25.4%) |
116
(85.9%) |
*<0.001 |
|
Mild nausea |
14 (20.9%) |
4 (3.0%) |
*<0.001 |
|
Moderate nausea |
19 (28.4%) |
12 (8.9%) |
*<0.001 |
|
Severe nausea |
17 (25.4%) |
3 (2.2%) |
*<0.001 |
Acute Vomiting Frequency |
1-2 times |
19 (28.4%) |
13 (9.6%) |
*0.001 |
|
3 times or more |
8 (11.9%) |
2 (1.5%) |
*0.002 |
|
None |
40 (59.7%) |
120 (88.9%) |
*<0.001 |
Acute Feeding Tolerance |
Yes |
21 (31.3%) |
90 (66.7%) |
*<0.001 |
|
No |
46 (68.7%) |
45 (33.3%) |
|
Acute Food Tolerance Degree (%) Categorize |
Severe |
30
(44.8%) |
20 (14.8%) |
*<0.001 |
|
Moderate |
10 (14.9%) |
12 (8.9%) |
0.222 |
|
Mild |
10 (14.9%) |
28 (20.7%) |
0.279 |
|
Normal |
17 (25.4%) |
75 (55.6%) |
*<0.001 |
Delayed Nausea Degree Categorize (%) |
No Nausea |
0 (0.0%) |
137 (100.0%) |
*<0.001 |
|
Mild nausea |
27 (38.6%) |
0 (0.0%) |
*<0.001 |
|
Moderate nausea |
26 (37.1%) |
0 (0.0%) |
*<0.001 |
|
Severe nausea |
17 (24.3%) |
0 (0.0%) |
*<0.001 |
Delayed Vomiting |
Yes |
36 (51.4%) |
3 (2.2%) |
*<0.001 |
|
No |
34 (48.6%) |
134 (97.8%) |
|
Delayed Vomiting Frequency |
1-2 times |
25 (35.7%) |
3
(2.2%) |
*<0.001 |
|
3 times or more |
11 (15.7%) |
0 (0.0%) |
*<0.001 |
|
None |
34 (48.6%) |
134 (97.8%) |
*<0.001 |
Delayed Food Tolerance |
Yes |
15 (21.4%) |
106 (77.4%) |
*<0.001 |
|
No |
55 (78.6%) |
31 (22.6%) |
|
Delayed Food Tolerance Degree (%) Categorize |
Severe |
29
(41.4%) |
8 (5.8%) |
*<0.001 |
|
Moderate |
14 (20.0%) |
10 (7.3%) |
*0.007 |
|
Mild |
16 (22.9%) |
28 (20.4%) |
0.687 |
|
Normal |
11 (15.7%) |
91 (66.4%) |
*<0.001 |